Shanghai Obio Technology (Group) Corp., Ltd. (SHA:688238)
7.71
+0.38 (5.18%)
At close: Mar 6, 2026
SHA:688238 Revenue
In the year 2025, Shanghai Obio Technology (Group) Corp. had annual revenue of 267.66M CNY with 7.86% growth. Shanghai Obio Technology (Group) Corp. had revenue of 87.31M in the quarter ending December 31, 2025, with 35.82% growth.
Revenue
267.66M
Revenue Growth
+7.86%
P/S Ratio
18.16
Revenue / Employee
386.80K
Employees
678
Market Cap
4.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 267.66M | 19.51M | 7.86% |
| Dec 31, 2024 | 248.15M | 43.34M | 21.16% |
| Dec 31, 2023 | 204.81M | -86.50M | -29.69% |
| Dec 31, 2022 | 291.30M | 36.36M | 14.26% |
| Dec 31, 2021 | 254.95M | 112.18M | 78.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.69B |
| Hefei Lifeon Pharmaceutical | 1.47B |
| Pulike Biological Engineering | 1.10B |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Assure Tech (Hangzhou) | 453.58M |
| Innovita Biological Technology | 422.03M |
| Guanhao Biotech | 392.83M |
| Beijing Scitop Bio-tech | 351.47M |